153 related articles for article (PubMed ID: 29296899)
1. What should be the goal of therapy for Waldenström macroglobulinemia patients? Complete response should be the goal of therapy.
Treon SP; Castillo JJ
Blood Adv; 2017 Nov; 1(25):2486-2490. PubMed ID: 29296899
[No Abstract] [Full Text] [Related]
2. Disease control should be the goal of therapy for WM patients.
Kastritis E; Dimopoulos MA
Blood Adv; 2017 Nov; 1(25):2483-2485. PubMed ID: 29296898
[No Abstract] [Full Text] [Related]
3. Drug-Related Pneumonitis During Mammalian Target of Rapamycin Inhibitor Therapy: Radiographic Pattern-Based Approach in Waldenström Macroglobulinemia as a Paradigm.
Nishino M; Boswell EN; Hatabu H; Ghobrial IM; Ramaiya NH
Oncologist; 2015 Sep; 20(9):1077-83. PubMed ID: 26205737
[TBL] [Abstract][Full Text] [Related]
4. Should minimal residual disease negativity
Sonneveld P
Blood Adv; 2017 Mar; 1(8):522-525. PubMed ID: 29296971
[No Abstract] [Full Text] [Related]
5. Antifibrinolytic therapy for preventing VWD-related postpartum hemorrhage: indications and limitations.
Kouides PA
Blood Adv; 2017 Apr; 1(11):699-702. PubMed ID: 29296712
[No Abstract] [Full Text] [Related]
6. Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214).
Treon SP; Meid K; Tripsas C; Heffner LT; Eradat H; Badros AZ; Xu L; Hunter ZR; Yang G; Patterson CJ; Gustine J; Castillo JJ; Matous J; Ghobrial IM
Clin Cancer Res; 2017 May; 23(10):2400-2404. PubMed ID: 27836860
[No Abstract] [Full Text] [Related]
7. Platelets as immune-sensing cells.
Kapur R; Semple JW
Blood Adv; 2016 Nov; 1(1):10-14. PubMed ID: 29296691
[No Abstract] [Full Text] [Related]
8. Hypoxia promotes dissemination and colonization in new bone marrow niches in Waldenström macroglobulinemia.
Muz B; de la Puente P; Azab F; Ghobrial IM; Azab AK
Mol Cancer Res; 2015 Feb; 13(2):263-72. PubMed ID: 25232031
[TBL] [Abstract][Full Text] [Related]
9. Genomics and proteomics in multiple myeloma and Waldenström macroglobulinemia.
Henry T; Fonseca R
Curr Opin Hematol; 2007 Jul; 14(4):369-74. PubMed ID: 17534163
[TBL] [Abstract][Full Text] [Related]
10. ATG in allogeneic stem cell transplantation: standard of care in 2017? Counterpoint.
Kekre N; Antin JH
Blood Adv; 2017 Mar; 1(9):573-576. PubMed ID: 29296977
[No Abstract] [Full Text] [Related]
11. Waldenström macroglobulinemia.
Gertz MA
Hematology; 2012 Apr; 17 Suppl 1():S112-6. PubMed ID: 22507796
[TBL] [Abstract][Full Text] [Related]
12. Related haploidentical donors are a better choice than matched unrelated donors: Counterpoint.
Shaw BE
Blood Adv; 2017 Feb; 1(6):401-406. PubMed ID: 29296955
[No Abstract] [Full Text] [Related]
13. Related haploidentical donors are a better choice than matched unrelated donors: Point.
Fuchs EJ
Blood Adv; 2017 Feb; 1(6):397-400. PubMed ID: 29296954
[No Abstract] [Full Text] [Related]
14. Emerging therapeutic options for Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Chakraborty R; Kapoor P; Ansell SM; Gertz MA
Expert Rev Anticancer Ther; 2015; 15(10):1143-56. PubMed ID: 26196236
[TBL] [Abstract][Full Text] [Related]
15. Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia.
Poulain S; Roumier C; Venet-Caillault A; Figeac M; Herbaux C; Marot G; Doye E; Bertrand E; Geffroy S; Lepretre F; Nibourel O; Decambron A; Boyle EM; Renneville A; Tricot S; Daudignon A; Quesnel B; Duthilleul P; Preudhomme C; Leleu X
Clin Cancer Res; 2016 Mar; 22(6):1480-8. PubMed ID: 26490317
[TBL] [Abstract][Full Text] [Related]
16. Should minimal residual disease negativity be the end point of myeloma therapy?
Anderson KC
Blood Adv; 2017 Mar; 1(8):517-521. PubMed ID: 29296970
[No Abstract] [Full Text] [Related]
17. Waldenstrom macroglobulinemia presenting with pancreatic mass: a case report and review of literature.
Nayak HK; Kar P; Bagchi A; Kapoor N; Kapahtia S; Sonika U; Kumar N; Kumar S
JOP; 2013 Jan; 14(1):92-5. PubMed ID: 23306344
[TBL] [Abstract][Full Text] [Related]
18. Blood volume-based von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease.
Ragni MV
Blood Adv; 2017 Apr; 1(11):703-706. PubMed ID: 29296713
[No Abstract] [Full Text] [Related]
19. Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO).
Simon L; Fitsiori A; Lemal R; Dupuis J; Carpentier B; Boudin L; Corby A; Aurran-Schleinitz T; Gastaud L; Talbot A; Leprêtre S; Mahe B; Payet C; Soussain C; Bonnet C; Vincent L; Lissandre S; Herbrecht R; Kremer S; Leblond V; Fornecker LM
Haematologica; 2015 Dec; 100(12):1587-94. PubMed ID: 26385211
[TBL] [Abstract][Full Text] [Related]
20. UNUSUAL SEROUS RETINAL DETACHMENT IN A PATIENT WITH WALDENSTROM MACROGLOBULINEMIA: A CASE REPORT.
Lin AB; Sheyman AT; Jampol LM
Retin Cases Brief Rep; 2019 Winter; 13(1):1-4. PubMed ID: 28106626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
